Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 9.31% vs -13.46% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 129.08% vs -502.86% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 335.71% vs -67.82% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -14.58% vs 108.70% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Pharming Group NV With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 9.31% vs -13.46% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 19.48% vs 36.51% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 129.08% vs -502.86% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 472.73% vs -191.67% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 335.71% vs -67.82% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 429.73% vs 70.16% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -14.58% vs 108.70% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 51.85% vs 17.39% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






